<html>
<head><title>
Prepared and filed by St Ives Financial
</title>
</head>
<body bgcolor="#FFFFFF">
<div style="page-break-before:always"></div>
<page>
<br>

<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td height="4" valign="bottom" bgcolor="#000000"></td>
  </tr>
  <tr>
    <td height="2" valign="top"></td>
  </tr>
  <tr>
    <td height="1" valign="top" bgcolor="#000000"></td>
  </tr>
</table>
<br>
   <table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="center"><font size="4" face="serif"><b>UNITED STATES</b></font></td>
</tr>
<tr valign="top">
<td align="center"><font size="4" face="serif"><b>SECURITIES AND EXCHANGE COMMISSION</b></font></td>
</tr>
<tr valign="top">
<td align="center"><font size="2" face="serif"><b>Washington, D.C. 20549</b></font></td>
</tr>
</table>
<p align="center"><b><font face="serif" size="4">FORM 8-K</font></b></p>  <table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="center"><font size="2" face="serif"><b>CURRENT REPORT</b></font></td>
</tr>
<tr valign="top">
<td align="center"><font size="2" face="serif"><b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></font></td>
</tr>
</table>
<p align="center"><font size="2" face="serif">Date of report (Date of earliest event reported):  November 9, 2006</font></p>  <table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="center"><font size="4" face="serif"><b><u>Impax Laboratories, Inc.</u></b></font></td>
</tr>
<tr valign="top">
<td align="center"><font size="2" face="serif">(Exact name of registrant as specified in its charter)</font></td>
</tr>
<tr valign="top">
<td>&nbsp;</td> </tr>
</table>
<br><br>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr align="center" valign="bottom" bgcolor="#ffffff">
<td><font size="2" face="serif"><b>Delaware</b></font></td>
<td width="5%">&nbsp;</td>
<td width="30%"><font size="2" face="serif"><b>0-27354</b></font></td>
<td width="5%">&nbsp;</td>
<td width="30%"><font size="2" face="serif"><b>65-0403311</b></font></td>
</tr>
<tr align="center" valign="bottom">
<td><hr noshade size="1"></td>
<td></td>
<td><hr noshade size="1"></td>
<td></td>
<td><hr noshade size="1"></td>
</tr>
<tr align="center" valign="bottom" bgcolor="#FFFFFF">
<td><font size="2" face="serif">(State or other jurisdiction</font><br><font size="2" face="serif">of incorporation)</font></td>
<td>&nbsp;</td>
<td><font size="2" face="serif">(Commission</font><br><font size="2" face="serif">File Number)</font></td>
<td>&nbsp;</td>
<td><font size="2" face="serif">(I.R.S. Employer</font><br><font size="2" face="serif">Identification No.)</font></td>
</tr>
</table>
<br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="center"><font size="2" face="serif"><b><u>30831 Huntwood Ave., Hayward, CA 94544</u></b></font></td>
</tr>
<tr valign="top">
<td align="center"><font size="2" face="serif">(Address of principal executive offices) (Zip Code)</font></td>
</tr>
</table>
<br>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top" bgcolor="#ffffff">
<td align="center"><font size="2" face="serif"><b><u>510-476-2000</u></b></font></td>
</tr>
<tr valign="top" bgcolor="#FFFFFF">
<td align="center"><font size="2" face="serif">(Registrant&#8217;s telephone number, including area code)  </font></td>
</tr>
</table>
<br>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="center"><font size="2" face="serif"><b><u>Not Applicable</u></b></font></td>
</tr>
<tr valign="top">
<td align="center"><font size="2" face="serif">(Former name or former address, if changed since last report)</font></td>
</tr>
</table>
<p align="left"><font size="2" face="serif">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></p>  <table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="5%"><img src="emptybox.gif"></td>
<td align="left"><font size="2" face="serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></td>
</tr>
<tr valign="top">
<td>&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
<td align="left" width="5%"><img src="emptybox.gif"></td>
<td align="left"><font size="2" face="serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></td>
</tr>
<tr valign="top">
<td>&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
<td align="left" width="5%"><img src="emptybox.gif"></td>
<td align="left"><font size="2" face="serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></td>
</tr>
<tr valign="top">
<td>&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
<td align="left" width="5%"><img src="emptybox.gif"></td>
<td align="left"><font size="2" face="serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></td>
</tr>
</table>
<p align="center">&nbsp;</p>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td height="1" valign="top" bgcolor="#000000"></td>
  </tr>
  <tr>
    <td height="2" valign="top" bgcolor="#FFFFFF"></td>
  </tr>
  <tr>
    <td height="4" valign="bottom" bgcolor="#000000"></td>
  </tr>
</table>
<hr noshade align="center" width="100%" size="2">
<div style="page-break-before:always"></div>
<page>
<table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
<td align="left" width="9%"><font size="2" face="serif"><b>Item 4.01&nbsp;&nbsp;&nbsp;</b></font></td>
<td align="left"><font size="2" face="serif"><b>Changes in Registrant&#8217;s Certifying Accountant.</b></font></td>
</tr>
</table>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On November 9, 2006, the registrant engaged Grant Thornton LLP (Grant Thornton) as its principal accountant to audit its financial statements beginning with the year ended December 31, 2005.  The registrant had not, prior to the engagement, consulted Grant Thornton regarding the application of accounting principles to any transaction, the type of opinion that might be rendered on the registrant&#8217;s financial statements, or any matter that was the subject of disagreement with its former accountant or a reportable event within the meaning of Item 304(a)(1)(v) of Regulation S-K under the Securities Exchange Act of 1934.</font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The registrant previously disclosed that Deloitte &amp; Touche LLP, which is currently engaged to audit the registrant&#8217;s financial statements for the year ended December 31, 2004, had informed the Company that it declined to stand for re-appointment as the registrant&#8217;s independent registered public accounting firm with respect to the year ending December 31, 2005 and would resign upon completion of its audit of the 2004 financial statements or upon its determination that it will be unable to complete the audit or issue a report on such financial statements.  </font></p>  <table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
  <td align="left"><font size="2" face="serif"><b>Item 9.01&nbsp;&nbsp;&nbsp;</b></font></td>
<td colspan="3" align="left"><font size="2" face="serif"><b>Financial Statements and Exhibits.</b></font></td>
</tr>
<tr valign="top">
  <td width="9%">&nbsp;</td>
<td width="6%">&nbsp;</td>
<td width="6%">&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td colspan="2" align="left"><font size="2" face="serif">(d)  Exhibits.</font></td>
</tr>
<tr valign="top">
  <td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
  <td align="left"></td>
<td align="left"></td>
<td align="left"></td>
<td align="left"><font size="2" face="serif">99.1 &#150; Press release dated November 9, 2006.</font></td>
</tr>
</table>
<p align="center"><font size="2" face="serif"><b>EXHIBIT INDEX</b></font></p>
<table width="100%" cellspacing="0" cellpadding="0" align="center" border="0">
<tr valign="top">
<td align="left"><font size="1" face="serif"><u>Exhibit No.</u></font></td>
<td align="left">&nbsp;</td>
<td align="left"><font size="1" face="serif"><u>Description</u></font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top">
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">&nbsp;</font></td>
<td align="left">&nbsp;</td>
</tr>
<tr valign="top" bgcolor="#ffffff">
<td align="left"><font size="2" face="serif">99.1</font></td>
<td align="left" width="2%">&nbsp;</td>
<td width="82%" align="left"><font size="2" face="serif">Press release dated November 9, 2006</font></td>
<td width="2%" align="left">&nbsp;</td> </tr>
</table>
<p align="center"><font size="2" face="serif"><b>SIGNATURES</b></font></p>
<p align="left"><font size="2" face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p align="left"><font size="2" face="serif">Dated:  November 9, 2006</font></p>  <table width="100%" cellspacing="0" cellpadding="0" border="0">
<tr valign="top">
  <td width="50%">&nbsp;</td>
<td colspan="2" align="left"><font size="2" face="serif">IMPAX LABORATORIES, INC.</font></td>
</tr>
<tr valign="top">
  <td width="50%">&nbsp;</td>
<td width="6%">&nbsp;</td>
<td>&nbsp;</td> </tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">By: </font></td>
<td align="left"><font size="2" face="serif">/s/ Arthur A. Koch, Jr.</font></td>
</tr>
<tr valign="top">
  <td></td>
<td></td>
<td><hr align="left" width="50%" size="1" noshade></td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">Name:</font></td>
<td align="left"><font size="2" face="serif">Arthur A. Koch, Jr.</font></td>
</tr>
<tr valign="top">
  <td align="left">&nbsp;</td>
<td align="left"><font size="2" face="serif">Title:</font></td>
<td align="left"><font size="2" face="serif">Chief Financial Officer</font></td>
</tr>
</table>
<br>
<br>
<br>
<p align="center"><font face="serif" size="2">2</font></p>
<hr noshade align="center" width="100%" size="2">
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "b415653_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 10805}]
{"company-data": {"conformed-name": "IMPAX LABORATORIES INC", "cik": "0001003642", "assigned-sic": "2834", "irs-number": "650403311", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-27354", "film-number": "061200453"}, "business-address": {"street1": "30831 HAYWARD AVE", "city": "HAYWARD", "state": "CA", "zip": "94544", "phone": "2152892220"}, "mail-address": {"street1": "CASTOR & KENSINGTON AVENUES", "city": "PHILADELPHIA", "state": "PA", "zip": "19124-5694"}, "former-company": {"former-conformed-name": "GLOBAL PHARMACEUTICAL CORP \\DE\\", "date-changed": "19951117"}}
Prepared and filed by St Ives Financial
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):  November 9, 2006
Impax Laboratories, Inc.
(Exact name of registrant as specified in its charter)
Delaware
0-27354
65-0403311
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
30831 Huntwood Ave., Hayward, CA 94544
(Address of principal executive offices) (Zip Code)
510-476-2000
(Registrant's telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 4.01
Changes in Registrant's Certifying Accountant.
On November 9, 2006, the registrant engaged Grant Thornton LLP (Grant Thornton) as its principal accountant to audit its financial statements beginning with the year ended December 31, 2005.  The registrant had not, prior to the engagement, consulted Grant Thornton regarding the application of accounting principles to any transaction, the type of opinion that might be rendered on the registrant's financial statements, or any matter that was the subject of disagreement with its former accountant or a reportable event within the meaning of Item 304(a)(1)(v) of Regulation S-K under the Securities Exchange Act of 1934.
The registrant previously disclosed that Deloitte & Touche LLP, which is currently engaged to audit the registrant's financial statements for the year ended December 31, 2004, had informed the Company that it declined to stand for re-appointment as the registrant's independent registered public accounting firm with respect to the year ending December 31, 2005 and would resign upon completion of its audit of the 2004 financial statements or upon its determination that it will be unable to complete the audit or issue a report on such financial statements.
Item 9.01
Financial Statements and Exhibits.
(d)  Exhibits.
99.1 – Press release dated November 9, 2006.
EXHIBIT INDEX
Exhibit No.
Description
99.1
Press release dated November 9, 2006
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated:  November 9, 2006
IMPAX LABORATORIES, INC.
By:
/s/ Arthur A. Koch, Jr.
Name:
Arthur A. Koch, Jr.
Title:
Chief Financial Officer
2